PrimeGen Biotech has a number of patents issued in a number of countries. The company also has a number of filed patents focused on innovative use of stem cells in regenerative medicine. One of the many goals has been to develop intellectual property to protect the concepts of cell-based therapies and to strengthen the ability for success with stem cell treatments.
PrimeGen Biotech is a privately held company with a portfolio of intellectual property focused on adipose derived stem cells. Interested investors may call or email to inquire about current investment opportunities.